The EU Commission conditionally approves an acquisition in the pharmaceuticals industry (Sanofi-Aventis / Zentiva)

"Mergers: main developments between 1 January and 30 April 2009"* On 4 February 2009 the European Commission approved, under the EU Merger Regulation, the proposed acquisition of the Czech generic pharmaceuticals firm Zentiva by Sanofi-Aventis Europe of France, a producer of originator medicines. To remedy the Commission’s competition concerns in different therapeutic areas on a number of national markets, Sanofi-Aventis undertook to divest fifteen drugs in the Czech

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • JG Associates (Brussels)

Quotation

John Gatti, The EU Commission conditionally approves an acquisition in the pharmaceuticals industry (Sanofi-Aventis / Zentiva), 4 February 2009, e-Competitions February 2009, Art. N° 37614

Visites 392

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues